Executive Director, CMC

Shubham Chopade, Ph.D. serves as Executive Director, CMC at Avenzo Therapeutics. He has over 20 years of experience in pharmaceutical development spanning early phase to late phase drug development.

Dr. Chopade most recently served as the Head of Pharmaceutical Development and Manufacturing at Kinnate Biopharma, a precision oncology company. At Kinnate, he established and led the CMC function and recruited a high-performing CMC team that supported Product and Process Development, Analytical Development, and Clinical Supply Chain. Prior to joining Kinnate, Dr. Chopade was the Head of Process Engineering and Scale-up at Nektar Therapeutics where he advanced multiple products through pivotal studies to NDA/MAA filing. Prior to Nektar, he held positions of increasing responsibilities at Irix Pharmaceuticals (now Patheon Thermofisher), while gaining extensive experience in Drug Substance development, manufacturing, and scale-up.

Dr. Chopade received his B.S., M.S., and Ph.D. degrees in Chemical Engineering from the Institute of Chemical Technology (ICT, formerly UDCT), University of Mumbai, India.